MP: DRDO 2DG dose becomes 'Sanjeevani' for Corona infected woman
MP: DRDO 2DG dose becomes 'Sanjeevani' for Corona infected woman
Share:

Indore: While the corona epidemic continues to wreak havoc across the country, scientists and doctors have not been able to find a permanent cure so far.  Plasma therapy and remdesivir have also been removed from the list of corona virus treatments by the World Health Organization (WHO), which was considered 'life-saving' in corona until a few days ago. Corona Medicine 2-DG of the Indian Defence Research and Development Organisation (DRDO) has become a ray of hope.

This medicine of DRDO is showing very positive results.  A similar case has come to light from CHL Hospital in Indore, Madhya Pradesh, where a woman undergoing corona treatment has benefited greatly from the 2-DG of DRDO.

In fact, Santosh Goyal CHL hospital is undergoing treatment in non-covid ward of Indore. She is a post covid patient whose oxygen level was continuously falling. After which he has been given the first dose of DRDO as 2-DG sachet on Sunday. Her health has improved very well only after taking the first dose.

The lady feels humbled and grateful for the efforts of Prime Minister, Shri Narendra Modi ji and the scientists of the DRDO.

The trial of 2-DG medicine has revealed that the drug is safe for COVID patients and also helps a lot in recovery. After positive results, DCGI approved the Phase III trial in November 2020. Finally, on 9th May, 2021, based on trial data, the DCGI allowed emergency use of the drug.

Also Read

Supreme Court to hear PIL over relief for borrowers

This foreign actress feel blessed to learn a lot of things from India

Corona update: India records positive response in active cases, death toll rises concern

Join NewsTrack Whatsapp group
Related News